Tag: Valneva

The biotechnology sector is renowned for its volatility, but the upcoming financial report from Valneva could unsettle even the most ...

The fate of Valneva, along with millions in investor capital, hinges on critical developments unfolding in the coming weeks. Behind ...

The shares of French biotechnology firm Valneva are exhibiting the characteristic volatility that defines the sector, swinging between investor optimism ...

Valneva shares are experiencing extreme volatility as the biotech firm navigates conflicting developments. While a major refinancing deal has resolved ...

Investors in Valneva are navigating turbulent waters as the biotechnology firm delivers a dual announcement: significantly reduced annual projections coupled ...

The French vaccine developer Valneva finds itself at a pivotal moment, with its future prospects increasingly tied to the success ...

Investors are celebrating a major turnaround for Valneva as the biopharmaceutical company released compelling long-term results for its Chikungunya vaccine ...

Valneva SA has encountered a significant regulatory obstacle as US health authorities suspended all distribution and sales of its recently ...

French biotechnology firm Valneva has encountered a severe regulatory obstacle following the US Food and Drug Administration's (FDA) immediate suspension ...

French vaccine developer Valneva faces a significant crisis after US regulators delivered a stunning blow. The Food and Drug Administration ...